(Total Views: 287)
Posted On: 09/08/2020 6:17:37 AM
Post# of 72
Tiny float here. Most shares are locked up in strong hands.
BTW, Generex Biotechnolgy (GNBT) have the US rights to sales of Excellagen as Gene Biotherapeutics(CRXM) sold those to Olaregen and Olaregen was purchased by Generex. Generex owes royalties to CRXM. Unfortunately sales of Excellagen have been slowed due to the VA hospital system having been impacted by Covid. Excellagen will be widely used for wound care in the VA's system when things get more normal and CRXM will receive revenue. There was expected to be $200 million plus sales to the VA per year. CRXM still has the worldwide rights for Excellagen.
BTW, Generex Biotechnolgy (GNBT) have the US rights to sales of Excellagen as Gene Biotherapeutics(CRXM) sold those to Olaregen and Olaregen was purchased by Generex. Generex owes royalties to CRXM. Unfortunately sales of Excellagen have been slowed due to the VA hospital system having been impacted by Covid. Excellagen will be widely used for wound care in the VA's system when things get more normal and CRXM will receive revenue. There was expected to be $200 million plus sales to the VA per year. CRXM still has the worldwide rights for Excellagen.
(0)
(0)Scroll down for more posts ▼
